Sandra Ring
Overview
Explore the profile of Sandra Ring including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pfeuffer L, Siegert V, Frede J, Rieger L, Trozzo R, de Andrade Kratzig N, et al.
Blood Cancer J
. 2024 Aug;
14(1):151.
PMID: 39198400
B-cell malignancies, such as chronic lymphocytic leukemia (CLL) and multiple myeloma (MM), remain incurable, with MM particularly prone to relapse. Our study introduces a novel mouse model with active RANK...
2.
Perez-Shibayama C, Gil-Cruz C, Cadosch N, Lutge M, Cheng H, De Martin A, et al.
Nat Cardiovasc Res
. 2024 Aug;
3(3):301-316.
PMID: 39196111
Myocarditis is an inflammatory heart disease that leads to loss of cardiomyocytes and frequently precipitates fibrotic remodeling of the myocardium, culminating in heart failure. However, the molecular mechanisms underlying immune...
3.
Berner F, Bomze D, Diem S, Ali O, Fassler M, Ring S, et al.
JAMA Oncol
. 2019 Apr;
5(7):1043-1047.
PMID: 31021392
Importance: Immunotherapy with checkpoint inhibitors targeting the PD-1 (programmed cell death 1) axis has brought notable progress in patients with non-small cell lung cancer (NSCLC) and other cancers. However, autoimmune...
4.
Fassler M, Diem S, Mangana J, Ali O, Berner F, Bomze D, et al.
J Immunother Cancer
. 2019 Feb;
7(1):50.
PMID: 30786924
Background: Long-term survival of stage IV melanoma patients has improved significantly with the development of immune checkpoint inhibitors (CIs). Reliable biomarkers to predict response and clinical outcome are needed. Methods:...
5.
Ring S, Flatz L
Methods Mol Biol
. 2016 Apr;
1404:351-364.
PMID: 27076310
Vaccination with a recombinant LCMV based vector expressing tumor-associated or viral antigens is a safe and versatile method to induce an immune response against tumors or viral infections. Here, we...
6.
Long K, Goldish M, Lown E, Ostrowski N, Alderfer M, Marsland A, et al.
Fam Syst Health
. 2015 Jan;
33(1):61-7.
PMID: 25581558
Prolonged, intensive treatment protocols for childhood cancer disrupt family routines and daily functioning, with effects extending to all family members. Despite their unique needs, siblings of children with cancer receive...